Copper Lake Resources Reports Results of Drilling at Marshall Lake Copper-Zinc-Silver VMS Property
TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Copper Lake Resources Ltd. (TSX-V: CPL, Frankfurt: WOI, OTC: WTCZF) (“Copper Lake” or...
TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Copper Lake Resources Ltd. (TSX-V: CPL, Frankfurt: WOI, OTC: WTCZF) (“Copper Lake” or...
Select Fruit Stiq features bold fruity flavors in a sleek, rechargeable 1G All-In-One cannabis oil vape NEW YORK, May 29,...
Contacts Investor Relations: Betsy Brod Affinity Growth Advisors Betsy.brod@affinitygrowth.com (917) 923-8541 Media: Robert Cavosi RooneyPartners rcavosi@rooneypartners.com (646) 638-9891 Virpax® Pharmaceuticals,...
Contacts Media Contact: Julie Murphy Thryv, Inc. 617.967.5426 julie.murphy@thryv.com Investor Contact: Cameron Lessard Thryv, Inc. 214.773.7022 cameron.lessard@thryv.com Thryv Holdings, Inc....
SINGAPORE, May 29, 2024 (GLOBE NEWSWIRE) -- Verde AgriTech Ltd. (TSX: NPK; OTCQX: VNPKF) ("Verde” or the “Company”) is pleased...
Atlanta, May 29, 2024 (GLOBE NEWSWIRE) -- – Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that...
Most shareholders can vote by calling 1-833-782-7145 Only one day left to vote PRINCETON, N.J., May 29, 2024 /PRNewswire/ --...
THE WOODLANDS, Texas, May 29, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the...
Contacts Amanda Butler Vice President, Investor Relations & Communications Tel: 216.383.2534 Email: Amanda_Butler@lincolnelectric.com Lincoln Electric Holdings, Inc. (Nasdaq: LECO) today...
SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing...
Contacts Investor investors@engene.com Media media@engene.com enGene Holdings Inc. (Nasdaq: ENGN or “enGene” or the “Company”), a clinical-stage genetic medicines company...
Contacts Shareholder/Analyst inquiries: Dawn Francfort ICR, Inc. investors@drivenbrands.com (203) 682-8200 Media inquiries: Taylor Blanchard taylor.blanchard@drivenbrands.com (704) 644-8129 Driven Brands Holdings...
Contacts Media: Kate Kirkpatrick VP, Communications mediainquiries@dollartree.com Investors: Robert A. LaFleur SVP, Investor Relations investorinfo@dollartree.com Dollar Tree, Inc. (NASDAQ: DLTR)...
TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative...
Contacts Investors: Scott Wisniewski investors@ast-science.com Media: Allison Eva Murphy Ryan 917-547-7289 AstSpaceMobile@allisonpr.com Verizon Katie Magnotta 201-602-9235 Katie.Magnotta@verizon.com AST SpaceMobile, Inc....
Read more at globenewswire.com
TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Golconda Gold Ltd. (“Golconda Gold” or the “Company”) (TSX-V: GG; OTCQB: GGGOF) is...
PHOENIX, AZ / ACCESSWIRE / May 29, 2024 / PetroSun, Inc (OTC PINK:PSUD) (the "Company") announced today the appointment of...
DENVER, Colo., May 29, 2024 (247marketnews.com)- Scorpius Holdings, Inc (NYSE:SCPX) reported its first quarter 2024 financial results and other updates....
-BHV-1510 is a novel trophoblast cell surface antigen-2 (Trop-2) directed antibody drug conjugate (ADC) that has demonstrated a highly differentiated...
MALVERN, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused...
CEO Cameron Chell to Highlight the Role of Drones and Draganfly in the New Global Economic and Political RealityLos Angeles,...
Additional large-animal study with commercial-size breast implants commenced in December 2023 expected to conclude in June 2024 Cash and cash...
Contacts CareDx, Inc. Media Relations Anna Czene 818-731-2203 aczene@caredx.com Investor Relations Greg Chodaczek Investor@caredx.com CareDx, Inc. (Nasdaq: CDNA), The Transplant...
Contacts For media inquiries, please contact: Dave Edlund, Co-Founder and CEO, Element 1 Corp; Phone: (541) 678-0005 Email: dave@e1na.com Kate...
Company Committed to Maximizing Value for All Shareholders; Strategic Alternatives Process UnderwayReaffirms Confidence in Business and Guidance of 21 EH/s...
MONTVALE, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and...
BOSTON, May 29, 2024 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the...
BOTHELL, Wash., May 29, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing...
Contacts Investor & Media Contact: David Burke Tel: (917) 618-2651 investorrelations@aldeyra.com Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology...
Contacts Adicet Bio, Inc. Investor and Media Contacts Anne Bowdidge abowdidge@adicetbio.com Janhavi Mohite Precision AQ 212-362-1200 janhavi.mohite@precisionaq.com Adicet Bio, Inc....
TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Red Pine Exploration Inc. (TSXV: RPX, OTCQB: RDEXF) (“Red Pine” or the “Company”)...
NEW YORK and SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company...
ST. PAUL, Minn., May 29, 2024 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and...
Contacts Surmodics Investor Inquiries: Jack Powell, Investor Relations ir@surmodics.com GTCR Media Contact: Andrew Johnson, Chief Marketing & Communications Officer andrew.johnson@gtcr.com...
Contacts Investor Relations & Media Contact: Robin Garner Vice President and Head of Investor Relations Repare Therapeutics Inc. investor@reparerx.com Repare...
Contacts Media & Investors Meg Dodge Media Kevin Giordano media@rocketpharma.com Investors Brooks Rahmer investors@rocketpharma.com Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a...
PITTSBURGH, May 29, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today...
Contacts Media: For Foundation Medicine Danielle Johns, 845-304-7408 newsroom@foundationmedicine.com For PMV Pharma Investors: Tim Smith Senior Vice President, Head of...
Origin’s cap production lines, the first of which is expected to come online during Q4 2024, are designed to mass...